SCHEMBL79194

SCHEMBL79194

SN1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL28867502 1.00 MGLL (0.42)
SCHEMBL15386448 0.87
SCHEMBL28071004 0.85 MGLL (0.33)
SCHEMBL21538586 0.85 MGLL (0.33)
Bicarbonate SCHEMBL11609855 0.85 HSD17B10 (0.44)
Formic Acid SCHEMBL11221746 0.83 CA12 (0.36)
Methane SCHEMBL11749753 0.79 CA12 (0.39)
Methane SCHEMBL11748578 0.79 CA12 (0.39)
SCHEMBL23436477 0.73 SMN1; SMN2 (0.44)
SCHEMBL21669920 0.70 CYP1A2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 964 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023036289-A1 HYDROXAMIC ACID COMPOUND HAVING ENPP1 INHIBITORY ACTIVITY AND USE THEREOF 上海海和药物研究开发股份有限公司 2023-03-16 WO claimed
EP-3894402-A1 N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2021-10-20 EP claimed
EP-3681884-A1 RAD51 INHIBITORS Cyteir Therapeutics, Inc. (US) 2020-07-22 EP claimed
US-20200222364-A1 CARBAZOLE DERIVATIVES FOR THE TREATMENT OF FIBROTIC DISEASES AND RELATED SYMPTOMS, AND CONDITIONS THEREOF RAZIEL THERAPEUTICS LTD. (IL) 2020-07-16 US claimed
WO-2020120528-A1 N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2020-06-18 WO claimed
US-10632102-B2 Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof RAZIEL THERAPEUTICS LTD (IL) 2020-04-28 US claimed
CN-106700140-B Improve rubber composition and the application of rubber ageing-resistant performance 北京彤程创展科技有限公司 2019-09-13 CN claimed
CN-109937042-A Backbone-modified morpholino oligonucleotides and chimeras synthesized using phosphoramidite chemistry 科罗拉多州立大学董事会法人团体 2019-06-25 CN claimed
CN-109836634-A Rubber composition and vulcanized rubber and its preparation method and application 中国石油化工股份有限公司 2019-06-04 CN claimed
CN-106032417-B Rubber composition and vulcanized rubber and its application 中国石油化工股份有限公司 2019-03-26 CN claimed
EP-0237955-A2 Quinolonecarboxylic acid derivatives and their preparation KYORIN PHARMACEUTICAL CO., LTD. (JP) 1987-09-23 EP claimed
EP-0219446-A1 Process for the preparation of N-tetrathiodimorpholine THE GOODYEAR TIRE & RUBBER COMPANY (US) 1987-04-22 EP claimed
CN-86101611-A N7Process for the preparation of amidino-substituted mitomycin C derivatives 1986-12-17 CN claimed
US-4614819-A REACTING A THIOL ESTER COMPOUND WITH 7-AMINOCEPHALOSPORIN IN PRESENCE OF BORON TRIFLUORIDE TOYAMA CHEMICAL CO., LTD. (JP) 1986-09-30 US claimed
US-4550162-A Process for the manufacture of enol derivatives CIBA-GEIGY CORPORATION (US) 1985-10-29 US claimed
US-4434287-A Cephalosporin derivatives CIBA-GEIGY CORPORATION (US) 1984-02-28 US claimed
US-4319027-A Process for the manufacture of ceohem enol derivatives CIBA-GEIGY CORPORATION (US) 1982-03-09 US claimed
US-4293462-A Process for the manufacture of enol derivatives, and intermediates CIBA-GEIGY CORPORATION (US) 1981-10-06 US claimed
US-4110533-A PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES CIBA-GEIGY CORPORATION (US) 1978-08-29 US claimed
US-4002594-A THIOMORPHOLINE PPG INDUSTRIES, INC. (US) 1977-01-11 US claimed